Coherus Biosciences | CHRS - Laba Operasional





Laba Operasional Perubahan Tanggal
AbbVie USD 6.88B 156M 2026-09
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
Akebia Therapeutics USD -5.45M 9.4M 2025-12
ALKERMES USD -65.93M 17.65M 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amarin USD -2.26M 564K 2025-12
Amgen USD 4.61B 777M 2026-06
Baxter International USD 314M 38M 2026-09
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eli Lilly USD 12.46B 2.68B 2026-06
Fujifilm JPY 101.76B 11.79B 2026-03
Gilead Sciences USD 3.85B 1.17B 2026-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Merck USD 7.33B 6.49B 2026-09
Myriad Genetics USD -3M 20.3M 2025-12
Pacira USD 9.96M 5.33M 2026-06
Perrigo USD 23.5M 10.1M 2026-06
Pfizer USD 662M 5M 2026-09
PTC Therapeutics USD 148.98M 103.09M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Teva Pharmaceutical Industries USD 235M 523M 2026-06
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09
Xencor USD -36.6M 41.26M 2026-06
Zoetis USD 1.12B 256M 2026-06